- Home
- PHR
PHR
Phreesia Inc.
as 11-14-2024 2:36pm EST
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $29.42 | AVG Volume (30 days): | 388.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.55 - $29.16 | Next Earning Date: | 12-09-2024 |
| Revenue: | $389,956,000 | Revenue Growth: | 22.10% |
| Revenue Growth (this year): | 18.82% | Revenue Growth (next year): | 14.79% |
Stock Insider Trading Activity of Phreesia Inc. (PHR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Linetsky David | PHR | SVP, Life Sciences | Oct 18 '24 | Sell | $20.49 | 1,100 | $22,539.00 | 200,207 | |
| VanDuyn Amy Beth | PHR | SVP, Human Resources | Oct 15 '24 | Sell | $21.03 | 624 | $13,119.66 | 118,917 | |
| Roberts Evan | PHR | Chief Operating Officer | Oct 15 '24 | Sell | $21.03 | 1,843 | $38,749.26 | 753,876 | |
| Linetsky David | PHR | SVP, Life Sciences | Oct 15 '24 | Sell | $21.03 | 2,011 | $42,281.48 | 200,207 | |
| Hoffman Allison C | PHR | General Counsel & Secretary | Oct 15 '24 | Sell | $21.03 | 1,212 | $25,482.42 | 119,791 | |
| Indig Chaim | PHR | Chief Executive Officer | Oct 15 '24 | Sell | $21.03 | 3,089 | $64,946.53 | 1,220,647 | |
| Gandhi Balaji | PHR | Chief Financial Officer | Oct 15 '24 | Sell | $21.03 | 864 | $18,165.69 | 97,714 | |
| Hui Yvonne | PHR | Principal Accounting Officer | Oct 15 '24 | Sell | $21.09 | 3,214 | $67,417.62 | 26,805 | |
| Linetsky David | PHR | SVP, Life Sciences | Sep 19 '24 | Sell | $24.04 | 24 | $577.04 | 200,207 | |
| Linetsky David | PHR | SVP, Life Sciences | Sep 17 '24 | Sell | $24.43 | 97 | $2,360.83 | 200,207 |
Latest Phreesia Inc. News
PHR Breaking Stock News: Dive into PHR Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates
Zacks
8 days ago
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last?
Business Wire
14 days ago
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
Business Wire
18 days ago
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
Insider Monkey
a month ago
Is Phreesia, Inc. (NYSE:PHR) The Top Stock With Improving Technical Ratings According To Piper Sandler?
Zacks
a month ago
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround
Business Wire
a month ago
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices
Business Wire
a month ago
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns
Compare PHR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PHR Phreesia Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.